General Information of This Drug (ID: DMB4JPG)

Drug Name
CNTX-4975   DMB4JPG
Indication
Disease Entry ICD 11 Status REF
Knee osteoarthritis FA01 Phase 3 [1]
Pain MG30-MG3Z Phase 3 [2]
Morton neuroma 8C11.6 Phase 2 [2]

List of Combinatorial Drugs (CBD) Containing This Drug

1 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
CNTX-4975 + Panobinostat DC7AWJ3 Panobinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03660943) A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.